Business● Low1h ago · Nov 5, 2026, 2:00 PM
Annovis Bio prices $21M public offering; shares slump
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Annovis Bio has priced a $21 million public offering, which led to a slump in its share price. This indicates market reaction to the company's latest financing activity.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business27m agoBarkin sees interest rate hikes ahead, but at a gradual paceCNBCBusiness27m agoAfter US$474m gamble flops, what happens now to Elon Musk’s Tesla, SpaceX and China ties?South China Morning PostBusiness28m agoFirst-time homebuyers remain scarce, but a record share of them pay all cashNPR NewsBusiness28m agoHere are the major earnings after the close ThursdaySeeking Alpha Tech